|
|
Article: ConjuGon Developing 'Trojan Horse' For Resistant Bacteria.(Company overview)
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
In the much-needed area of antibiotic-resistant infections, Wisconsin start-up ConjuGon Inc. is developing therapeutics that will attack bacteria by using the pathogens' own abilities to evolve.
Founded in 2001 as a spin-out from the University of Wisconsin-Madison by professors Marcin Filutowicz and Richard Burgess, ConjuGon was so named based on the core technology developed by Filutowicz and exclusively licensed from the Wisconsin Alumni Research Foundation (WARF).
That technology is designed to take advantage of the naturally occurring process of bacterial conjugation, the same process that helps bacteria build up resistance to ...